Sponsor Information
JANSSEN-CILAG PTY LTD
Active Ingredients
Ustekinumab
422773
SETRELVO ustekinumab 45 mg/0.5 mL solution for injection pre-filled syringe
Janssen-Cilag Pty Ltd
July 22, 2024
Medicine
Medicine
Registered
JANSSEN-CILAG PTY LTD
Ustekinumab
Empowering clinical research with data-driven insights and AI-powered tools.
© 2025 MedPath, Inc. All rights reserved.